Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
platelet-rich plasma + fibrin glue
- Development stage
- Phase 3
- Lead developer
- Shahid Beheshti University of Medical Sciences
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical, Surgical, Intralesional, Intraarticular, Intraosseous, Periodontal
01
Overview
Platelet-rich plasma + fibrin glue is a combination of two autologous blood-derived biomaterials used primarily to promote wound healing and tissue regeneration. Platelet-rich plasma (PRP) is a concentrate of platelets suspended in plasma, rich in growth factors that stimulate cell proliferation and tissue repair. Fibrin glue (also called fibrin sealant) is formed by polymerizing concentrated fibrinogen with thrombin and calcium, resulting in a strong clot that provides hemostasis and acts as a scaffold for cell migration. When combined, PRP supplies bioactive growth factors while the fibrin matrix offers structural support at the application site. This combination has been investigated for use in chronic wound healing (such as diabetic foot ulcers), surgical anastomoses, bone grafting procedures, periodontal regeneration, soft tissue repair, orthopedic surgery, and other reconstructive applications[1][2][6]. The product is typically prepared from autologous blood immediately prior to use.
- Other names
- platelet-rich plasma-fibrin gluePRP-FGPRP + fibrin glue
02
Targets
TGFBR (TGF-beta receptor)PDGFR (PDGFR family)VEGFR (VEGFR family)
Beyond the preview
Go deeper on platelet-rich plasma + fibrin glue.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on platelet-rich plasma + fibrin glue.